Mather Group’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$133K Hold
975
﹤0.01% 864
2026
Q1
$115K Buy
+975
New +$136K ﹤0.01% 863
2025
Q4
Sell
-979
Closed -$131K 1426
2025
Q3
$131K Buy
+979
New +$119K ﹤0.01% 717
2025
Q2
Sell
-987
Closed -$126K 1468
2025
Q1
$126K Hold
987
﹤0.01% 702
2024
Q4
$142K Hold
987
﹤0.01% 664
2024
Q3
$147K Sell
987
-40
-4% -$5.74K ﹤0.01% 658
2024
Q2
$189K Buy
1,027
+985
+2,345% +$154K ﹤0.01% 630
2024
Q1
$7.55K Buy
+42
New +$8K ﹤0.01% 1272
2023
Q3
Sell
-975
Closed -$138K 609
2023
Q2
$138K Buy
+975
New +$156K ﹤0.01% 559

Other funds holding RGEN

Mather Group's RGEN Position: Q2 2026 in Review

Mather Group held its Repligen (RGEN) position steady in Q2 2026 at 975 shares worth $133K. The position accounts for ﹤0.01% of the portfolio, ranked #864.

Mather Group first reported a position in RGEN in Q2 2023 and has held it in 9 quarters since. The position peaked at $189K in Q2 2024. 482 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • Mather Group held 975 shares of Repligen worth $133K as of Q2 2026.
  • Mather Group left its Repligen share count unchanged in Q2 2026.
  • Repligen made up ﹤0.01% of Mather Group's portfolio in Q2 2026, its #864 holding.
  • Mather Group first reported a position in Repligen in Q2 2023 and has held it in 9 quarters since.
  • Mather Group's Repligen position peaked at $189K in Q2 2024.
  • 482 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Mather Group's 13F filing for Q2 2026, filed 27 Jul 2026.